Patrick Enright

Patrick Enright

Direttore/Membro del Consiglio presso VERA THERAPEUTICS, INC.

Patrimonio netto: 90 M $ in data 31/08/2026

64 anni
Health Technology
Commercial Services
Finance

Profilo

Mr. Patrick G.
Enright
is an Independent Director at Veradermics, Inc., an Independent Director at BioAge Labs, Inc., an Independent Director at Zenas BioPharma, Inc., an Independent Director at Vera Therapeutics, Inc., a Chairman at CuraSen Therapeutics, Inc., an Independent Director at Jazz Pharmaceuticals Plc and a Managing Director at Longitude Capital Management Co LLC.
He is on the Board of Directors at Veradermics, Inc., BioAge Labs, Inc., Zenas BioPharma, Inc., Opna Immuno-Oncology SA, Endeavor BioMedicines, Inc, Vera Therapeutics, Inc., Epirium Bio, Inc., Orbus Therapeutics, Inc., Lemo USA, Inc., Jazz Pharmaceuticals Plc, InfaCare Pharmaceutical Corp.
and Raven Biotechnologies, Inc. Mr. Enright was previously employed as an Independent Director by SutroVax, Inc., an Independent Director by Esperion Therapeutics, Inc., an Independent Director by CardioDx, Inc., an Independent Director by Corcept Therapeutics, Inc., a Managing Director by Pequot Ventures, a Managing Director by Pequot Capital Corp., a Senior VP-Finance & Business Development by Boehringer Mannheim Pharmaceuticals Corp., a Managing Member by Delta Opportunity Fund LLC, a Vice President by PaineWebber Development Corp., a Principal by Geneva Pharmaceuticals, Inc., a Chief Financial Officer & SVP-Business Development by Valentis, Inc., and a Chief Financial Officer & Senior Vice President by Urigen Pharmaceuticals, Inc. He also served on the board at Dascena, Inc., National Venture Capital Association, Rivus Pharmaceuticals, Inc., Aptinyx, Inc., Aimmune Therapeutics, Inc., Jazz Pharmaceuticals, Inc., Sequenom, Inc., Threshold Pharmaceuticals, Inc., Codexis, Inc., Horizon Therapeutics Ltd. (Ireland), MAP Pharmaceuticals, Inc., DiObex, Inc., Horizon Therapeutics, Inc., Prestwick Pharmaceuticals, Inc., Tecan Genomics, Inc. and Xanodyne Pharmaceuticals, Inc. He received his undergraduate degree from Stanford University and an MBA from The Wharton School of the University of Pennsylvania.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
4,02%
15/06/2026 2.619.189 ( 4,02% ) 85 M $ 31/08/2026
31/08/2026 21.278 ( 0,03% ) 5 M $ 31/08/2026
21/05/2026 5.882 ( 0,01% ) 200 459 $ 31/08/2026
10/06/2026 0 ( -.--% ) - $ 31/08/2026

Posizioni attive di Patrick Enright

SocietàPosizioneInizio
VERA THERAPEUTICS, INC. Direttore/Membro del Consiglio 01/11/2020
JAZZ PHARMACEUTICALS PLC Direttore/Membro del Consiglio 01/07/2009
BIOAGE LABS, INC. Direttore/Membro del Consiglio 01/02/2024
VERADERMICS, INCORPORATED Direttore/Membro del Consiglio 01/12/2024
Direttore/Membro del Consiglio 01/06/2019
Direttore/Membro del Consiglio 01/01/2012
Direttore/Membro del Consiglio 01/12/2020
Direttore/Membro del Consiglio 01/06/2022
Direttore/Membro del Consiglio -
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░

Precedenti posizioni note di Patrick Enright

SocietàPosizioneFine
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Patrick Enright

Formazione di Patrick Enright

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

74

Relazioni di 1° grado

43

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private43

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Technology

Process Industries

Health Technology

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Delta Opportunity Fund LLC

Consumer Services

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Boehringer Mannheim Pharmaceuticals Corp.

Finance

PaineWebber Development Corp.

Electronic Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Mercati
  2. Insiders
  3. Patrick Enright
40% di sconto: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA